[HTML][HTML] Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li… - The Journal of …, 2006 - Am Soc Clin Investig
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

S Fazel, M Cimini, L Chen, S Li… - Journal of Clinical …, 2006 - search.ebscohost.com
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

[HTML][HTML] Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li… - Journal of Clinical …, 2006 - ncbi.nlm.nih.gov
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective c-kit^ sup+^ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li - Journal of Clinical …, 2006 - search.proquest.com
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li… - The Journal of …, 2006 - pubmed.ncbi.nlm.nih.gov
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective [c-kit. sup.+] cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

S Fazel, M Cimini, L Chen, S Li, D Angoulvant… - Journal of Clinical …, 2006 - go.gale.com
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines.

S Fazel, M Cimini, L Chen, S Li… - The Journal of …, 2006 - europepmc.org
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li, D Angoulvant, P Fedak… - 2006 - Am Soc Clin Investig
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …

[引用][C] Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S FAZEL - J Clin Invest, 2006 - cir.nii.ac.jp
Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance
of angiogenic cytokines | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

[PDF][PDF] Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines

S Fazel, M Cimini, L Chen, S Li, D Angoulvant, P Fedak… - Am Soc Clin Investig
Clinical trials of bone marrow stem/progenitor cell therapy after myocardial infarction (MI)
have shown promising results, but the mechanism of benefit is unclear. We examined the …